Georgetown University Medical Center
Clinical research site in Washington D.C., District of Columbia · MedStar Georgetown Univ Hospital, 3800 Reservoir Rd NW, Washington, DC 20007 · (202) 444-2000 · Website
As of September 2026, 43 paid clinical trials are recruiting at Georgetown University Medical Center in Washington D.C., District of Columbia. Active studies at this site cover conditions such as Breast Cancer, Locally Advanced Solid Tumor and Metastatic Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Georgetown University Medical Center (43)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Study of XB010 in Subjects With Solid Tumors
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
CoMind Early Feasibility Study
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Home-based Vision Rehabilitation Guided by Brain Imaging
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
ETHAN - ET for Male BC
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Tobacco Education and Lung Health Study (TEAL)
Mindful Self-Compassion for Anxiety Disorders and Depression
Visual Plasticity Following Brain Lesions
ReadMap: Reading in Stroke Alexia and Typical Aging
Showing the 40 most relevant of 43 recruiting trials at this site. Browse all with filters →
Get new-trial alerts for Georgetown University Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Washington D.C., DC. Unsubscribe anytime.
More research sites in Washington D.C.
- MedStar Washington Hospital Center (96 trials)
- Children's National Medical Center (87 trials)
- Children's National Hospital (84 trials)
- MedStar Georgetown University Hospital (73 trials)
- Sibley Memorial Hospital (45 trials)
- Georgetown University (38 trials)
- George Washington University (18 trials)
- George Washington University Medical Center (17 trials)
- Children's National Health System (11 trials)
- Georgetown Lombardi Comprehensive Cancer Center (11 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Washington D.C., DC · District of Columbia clinical trials